Stock XCRT XCELERATE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Xcelerate Inc.

Equities

XCRT

US98401T1051

Healthcare Facilities & Services

Market Closed - OTC Markets
Other stock markets
 11:02:05 16/05/2024 pm IST 		5-day change 1st Jan Change
0.034 USD -0.18% Intraday chart for Xcelerate Inc. -0.87% -5.56%
29/04 Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Xcelerate Inc. has filed an IPO in the amount of $17.25 million. CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 11.94 30.57 13.35 15.63
Enterprise Value (EV) 1 11.96 30.73 13.46 16.84
P/E ratio -896 x -108 x -16 x -5.46 x
Yield - - - -
Capitalization / Revenue - - - 1,39,30,646 x
EV / Revenue - - - 1,50,04,302 x
EV / EBITDA - - - -66,32,711 x
EV / FCF - - - 7,31,79,126 x
FCF Yield - - - 0%
Price to Book -579 x -140 x -745 x -93.9 x
Nbr of stocks (in thousands) 2,51,321 3,55,446 3,81,446 4,34,446
Reference price 2 0.0475 0.0860 0.0350 0.0360
Announcement Date 19/05/22 19/05/22 28/04/23 29/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - - - 1.122
EBITDA - - - -2.538
EBIT 1 -0.0132 -0.2895 -0.8446 -2.613
Operating Margin - - - -232.84%
Earnings before Tax (EBT) 1 -0.0132 -0.2895 -0.8446 -2.89
Net income 1 -0.0132 -0.2895 -0.8446 -2.751
Net margin - - - -245.14%
EPS 2 -0.000053 -0.000794 -0.002191 -0.006593
Free Cash Flow - - - 0.2301
FCF margin - - - 20.5%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 19/05/22 19/05/22 28/04/23 29/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 0.02 0.17 0.11 1.2
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - - - -0.4746 x
Free Cash Flow - - - 0.23
ROE (net income / shareholders' equity) - 238% 698% 3,303%
ROA (Net income/ Total Assets) - - - -152%
Assets 1 - - - 1.809
Book Value Per Share 2 -0 -0 -0 -0
Cash Flow per Share - - 0 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 19/05/22 19/05/22 28/04/23 29/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
XCELERATE INC. Stock Xcelerate Inc.
-5.56% 14.8M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+19.22% 85.64B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-27.14% 70.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+4.65% 27.05B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-6.23% 17.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+1.60% 17.58B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+3.30% 15.64B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+7.27% 13.55B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+9.91% 13.41B
NATERA, INC. Stock Natera, Inc.
+73.32% 13.18B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. XCRT Stock
  4. Financials Xcelerate Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW